Showing results (301-310 of 554) with videos related to
Sort By:
Pageof 56
American Journal of Human Genetics|June 15, 2007
Autosomal dominant nonsyndromic cleft lip and palate: significant evidence of linkage at 18q21.1Soraya Beiraghi, Swapan K Nath, Matthew Gaines, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2019
Phase II Trial of a DNA Vaccine Encoding Prostatic Acid Phosphatase (pTVG-HP [MVI-816]) in Patients With Progressive, Nonmetastatic, Castration-Sensitive Prostate CancerDouglas G McNeel, Jens C Eickhoff, Laura E Johnson, et al.Academic Radiology|April 9, 2018
Multiparametric Whole-body MRI with Diffusion-weighted Imaging and ADC Mapping for the Identification of Visceral and Osseous Metastases From Solid TumorsMichael A Jacobs, Katarzyna J Macura, Atif Zaheer, et al.The Prostate|March 14, 2022
Clinical and pathological features associated with circulating tumor DNA content in real-world patients with metastatic prostate cancerEmmanuel S Antonarakis, Marni Tierno, Virginia Fisher, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 16, 2021
Detection of Early Progression with 18F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen TherapyMark C Markowski, Pedro Isaacsson Velho, Mario A Eisenberger, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2022
A Phase Ib/II Study of Sabizabulin, a Novel Oral Cytoskeleton Disruptor, in Men with Metastatic Castration-resistant Prostate Cancer with Progression on an Androgen Receptor-targeting AgentMark C Markowski, Ronald Tutrone, Christopher Pieczonka, et al.The Prostate|August 8, 2019
Genomic and clinical characterization of pulmonary-only metastatic prostate cancer: A unique molecular subtypeEugene Shenderov, Pedro Isaacsson Velho, Anas H Awan, et al.The Prostate|July 13, 2011
Lenalidomide modulates IL-8 and anti-prostate antibody levels in men with biochemically recurrent prostate cancerDaniel J Zabransky, Heath A Smith, Christopher J Thoburn, et al.European Urology|February 15, 2018
Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and EnzalutamideEmmanuel S Antonarakis, Changxue Lu, Brandon Luber, et al.Cancer Chemotherapy and Pharmacology|October 25, 2011
Phase I rapid dose-escalation study of AGS-1C4D4, a human anti-PSCA (prostate stem cell antigen) monoclonal antibody, in patients with castration-resistant prostate cancer: a PCCTC trialEmmanuel S Antonarakis, Michael A Carducci, Mario A Eisenberger, et al.Pageof 56